Play it in E or G: Utilization of HLA-E and -G in xenotransplantation

Xenotransplantation

Volumn 14, Issue 3, 2007, Pages 198-207

  Crew, Mark D ^a  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

CD94; HLA E; HLA G; NK cell; NKG2A; NKG2D; Xenotransplantation

Indexed keywords

HLA E ANTIGEN; HLA G ANTIGEN;

CELL ACTIVATION; GENETIC POLYMORPHISM; HUMAN; LIGAND BINDING; MEMBRANE POTENTIAL; MOLECULAR DYNAMICS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TREATMENT OUTCOME; XENOTRANSPLANTATION;

ANIMALS; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; MODELS, ANIMAL; PRIMATES; SUS SCROFA; TRANSPLANTATION, HETEROLOGOUS;

EID: 34247876002     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2007.00395.x     Document Type: Review

References (99)

1. Phelps CJ, Koike C, Vaught TD et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003 299 : 411.
2. Lai L, Kolber-Simonds D, Park KW et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002 295 : 1089.
3. Kuwaki K, Tseng YL, Dor FJ et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005 11 : 29.
4. Yamada K, Yazawa K, Shimizu A et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005 11 : 32.
5. Baumann BC, Forte P, Hawley RJ et al. Lack of galactose-alpha-1,3- galactose expression on porcine endothelial cells prevents complement-induced lysis but not direct xenogeneic NK cytotoxicity. J Immunol 2004 172 : 6460.
6. Itescu S, Artrip JH, Kwiatkowski PA et al. Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products. Ann Transplant 1997 2 : 14.
7. Kwiatkowski P, Artrip JH, John R et al. Induction of swine major histocompatibility complex class I molecules on porcine endothelium by tumor necrosis factor-alpha reduces lysis by human natural killer cells. Transplantation 1999 67 : 211.
8. Matter-Reissmann UB, Forte P, Schneider MK et al. Xenogeneic human NK cytotoxicity against porcine endothelial cells is perforin/granzyme B dependent and not inhibited by Bcl-2 overexpression. Xenotransplantation 2002 9 : 325.
9. Schneider MK, Forte P, Seebach JD. Adhesive interactions between human NK cells and porcine endothelial cells. Scand J Immunol 2001 54 : 70.
10. Tsuyuki S, Horvath-Arcidiacono JA, Bloom ET. Effect of redox modulation on xenogeneic target cells: the combination of nitric oxide and thiol deprivation protects porcine endothelial cells from lysis by IL-2-activated human NK cells. J Immunol 2001 166 : 4106.
11. Horvath-Arcidiacono JA, Bloom ET. Characterization of human killer cell reactivity against porcine target cells: differential modulation by cytokines. Xenotransplantation 2001 8 : 62.
12. Xu XC, Goodman J, Sasaki H et al. Activation of natural killer cells and macrophages by porcine endothelial cells augments specific T-cell xenoresponse. Am J Transplant 2002 2 : 314.
13. Quan D, Bravery C, Chavez G et al. Identification, detection, and in vitro characterization of cynomolgus monkey natural killer cells in delayed xenograft rejection of hDAF transgenic porcine renal xenografts. Transplant Proc 2000 32 : 936.
14. Khalfoun B, Barrat D, Watier H et al. Development of an ex vivo model of pig kidney perfused with human lymphocytes. Analysis of xenogeneic cellular reactions. Surgery 2000 128 : 447.
15. Chen D, Weber M, Lechler R, Dorling A. NK-cell-dependent acute xenograft rejection in the mouse heart-to-rat model. Xenotransplantation 2006 13 : 408.
16. Lopez-Botet M, Bellon T. Natural killer cell activation and inhibition by receptors for MHC class I. Curr Opin Immunol 1999 11 : 301.
17. Colucci F, DiSanto JP, Leibson P. Natural Killer cell activation in mice and men: different triggers for similar weapons? Nat Immunol 2002 3 : 807.
18. McQueen KL, Parham P. Variable receptors controlling activation and inhibition of NK cells. Curr Opin Immunol 2002 14 : 615.
19. Natarajan K, Dimasi N, Wang J et al. Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol 2002 20 : 853.
20. Sullivan JA, Oettinger HF, Sachs DH, Edge AS. Analysis of polymorphism in porcine MHC class I genes: alterations in signals recognized by human cytotoxic lymphocytes. J Immunol 1997 159 : 2318.
21. Crew MD, Phanavanh B. Exploiting virus stealth technology for xenotransplantation: reduced human T cell responses to porcine cells expressing herpes simplex virus ICP47. Xenotransplantation 2003 10 : 50.
22. Forte P, Lilienfeld BG, Baumann BC, Seebach JD. Human NK cytotoxicity against porcine cells is triggered by NKp44 and NKG2D. J Immunol 2005 175 : 5463.
23. Garcia-Borges CN, Phanavanh B, Saraswati S et al. Molecular cloning and characterization of a porcine UL16 binding protein (ULBP)-like cDNA. Mol Immunol 2005 42 : 665.
24. Lilienfeld BG, Garcia-Borges C, Crew MD, Seebach JD. Porcine UL16-binding protein 1 expressed on the surface of endothelial cells triggers human NK cytotoxicity through NKG2D. J Immunol 2006 177 : 2146.
25. Seebach JD, Comrack C, Germana S et al. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells. J Immunol 1997 159 : 3655.
26. Sharland A, Patel A, Lee JH et al. Genetically modified HLA class I molecules able to inhibit human NK cells without provoking alloreactive CD8+ CTLs. J Immunol 2002 168 : 3266.
27. Geraghty DE, Stockschleader M, Ishitani A, Hansen JA. Polymorphism at the HLA-E locus predates most HLA-A and -B polymorphism. Hum Immunol 1992 33 : 174.
28. Marsh SG, Albert ED, Bodmer WF et al. Nomenclature for factors of the HLA system, 2004. Tissue Antigens 2005 65 : 301.
29. Lee N, Goodlett DR, Ishitani A et al. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol 1998 160 : 4951.
30. Braud VM, Allan DS, Wilson D, McMichael AJ. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr Biol 1998 8 : 1.
31. Borrego F, Ulbrecht M, Weiss EH et al. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 1998 187 : 813.
32. Michaelsson J, Teixeira de Matos C, Achour A et al. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J Exp Med 2002 196 : 1403.
33. Wooden SL, Kalb SR, Cotter RJ, Soloski MJ. Cutting edge: HLA-E binds a peptide derived from the ATP-binding cassette transporter multidrug resistance-associated protein 7 and inhibits NK cell-mediated lysis. J Immunol 2005 175 : 1383.
34. Tomasec P, Braud VM, Rickards C et al. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 2000 287 : 1031.
35. Pietra G, Romagnani C, Mazzarino P et al. HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. Proc Natl Acad Sci U S A 2003 100 : 10896.
36. Hoare HL, Sullivan LC, Pietra G et al. Structural basis for a major histocompatibility complex class Ib-restricted T cell response. Nat Immunol 2006 7 : 256.
37. Braud VM, Allan DS, O'Callaghan CA et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998 391 : 795.
38. Lee N, Llano M, Carretero M et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci U S A 1998 95 : 5199.
39. Navarro F, Llano M, Bellon T et al. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol 1999 29 : 277.
40. Brooks AG, Borrego F, Posch PE et al. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. J Immunol 1999 162 : 305.
41. Vales-Gomez M, Reyburn HT, Erskine RA et al. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J 1999 18 : 4250.
42. Wada H, Matsumoto N, Maenaka K et al. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues. Eur J Immunol 2004 34 : 81.
43. Shilling HG, Young N, Guethlein LA et al. Genetic control of human NK cell repertoire. J Immunol 2002 169 : 239.
44. Valiante NM, Uhrberg M, Shilling HG et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997 7 : 739.
45. Sasaki H, Xu XC, Mohanakumar T. HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94/NKG2-dependent and -independent pathways. J Immunol 1999 163 : 6301.
46. Matsunami K, Miyagawa S, Nakai R et al. Modulation of the leader peptide sequence of the HLA-E gene up-regulates its expression and down-regulates natural killer cell-mediated swine endothelial cell lysis. Transplantation 2002 73 : 1582.
47. Forte P, Baumann BC, Weiss EH, Seebach JD. HLA-E expression on porcine cells: protection from human NK cytotoxicity depends on peptide loading. Am J Transplant 2005 5 : 2085.
48. Crew MD, Cannon MJ, Phanavanh B, Garcia-Borges CN. An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells. Mol Immunol 2005 42 : 1205.
49. Lilienfeld BG, Crew MD, Forte P et al. Transgenic expression of HLA-E single chain trimer protects porcine endothelial cells against human NK-mediated cytotoxicity. Xenotransplantation 2007 14 : 126 134.
50. Carosella ED, Moreau P, Le Maoult J et al. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 2003 81 : 199.
51. Tripathi P, Agrawal S. Non-classical HLA-G antigen and its role in the cancer progression. Cancer Invest 2006 24 : 178.
52. Hunt JS. Stranger in a strange land. Immunol Rev 2006 213 : 36.
53. Lee N, Malacko AR, Ishitani A et al. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 1995 3 : 591 600.
54. Diehl M, Munz C, Keilholz W et al. Nonclassical HLA-G molecules are classical peptide presenters. Curr Biol 1996 6 : 305 314.
55. Lenfant F, Pizzato N, Liang S et al. Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice. J Gen Virol 2003 84 : 307 317.
56. Devergne O, Hummel M, Koeppen H et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol 1996 70 : 1143 1150.
57. Ishitani A, Sageshima N, Lee N et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 2003 171 : 1376 1384.
58. Horuzsko A, Antoniou J, Tomlinson P et al. Int Immunol 1997 9 : 645.
59. Rajagopalan S, Long EO. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 1999 189 : 1093.
60. Rajagopalan S, Fu J, Long EO. Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J Immunol 2001 167 : 1877.
61. Faure M, Long EO. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J Immunol 2002 168 : 6208.
62. Colonna M, Navarro F, Bellon T et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 1997 186 : 1809.
63. Colonna M, Samaridis J, Cella M et al. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 1998 160 : 3096.
64. Kikuchi-Maki A, Yusa S, Catina TL, Campbell KS. KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. J Immunol 2003 171 : 3415.
65. Goodridge JP, Witt CS, Christiansen FT, Warren HS. KIR2DL4 (CD158d) genotype influences expression and function in NK cells. J Immunol 2003 171 : 1768.
66. Boyington JC, Motyka SA, Schuck P et al. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 2000 405 : 537.
67. Willcox BE, Thomas LM, Bjorkman PJ. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat Immunol 2003 4 : 913.
68. Shiroishi M, Kuroki K, Rasubala L et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d). Proc Natl Acad Sci U S A 2006 103 : 16412.
69. Boyson JE, Erskine R, Whitman MC et al. Disulfide bond-mediated dimerization of HLA-G on the cell surface. Proc Natl Acad Sci U S A 2002 99 : 16180.
70. Shiroishi M, Kuroki K, Ose T et al. Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J Biol Chem 2006 281 : 10439.
71. Sasaki H, Xu XC, Smith DM et al. HLA-G expression protects porcine endothelial cells against natural killer cell-mediated xenogeneic cytotoxicity. Transplantation 1999 67 : 31.
72. Seebach JD, Pazmany L, Waneck GL et al. HLA-G expression on porcine endothelial cells protects partially against direct human NK cytotoxicity but not against ADCC. Transplant Proc 1999 31 : 1864.
73. Forte P, Matter-Reissmann UB, Strasser M et al. Porcine aortic endothelial cells transfected with HLA-G are partially protected from xenogeneic human NK cytotoxicity. Hum Immunol 2000 61 : 1066.
74. Forte P, Pazmany L, Matter-Reissmann UB et al. HLA-G inhibits rolling adhesion of activated human NK cells on porcine endothelial cells. J Immunol 2001 167 : 6002.
75. Matsunami K, Miyagawa S, Nakai R et al. The possible use of HLA-G1 and G3 in the inhibition of NK cell-mediated swine endothelial cell lysis. Clin Exp Immunol 2001 126 : 165.
76. Morris MA, Ley K. Trafficking of natural killer cells. Curr Mol Med 2004 4 : 431.
77. Dorling A, Monk NJ, Lechler RI. HLA-G inhibits the transendothelial migration of human NK cells. Eur J Immunol 2000 30 : 586.
78. Walzer T, Dalod M, Robbins SH et al. Natural-killer cells and dendritic cells: "l'union fait la force". Blood 2005 106 : 2252.
79. Braud VM, Aldemir H, Breart B, Ferlin WG. Expression of CD94-NKG2A inhibitory receptor is restricted to a subset of CD8(+) T cells. Trends Immunol 2003 24 : 162.
80. McMahon CW, Raulet DH. Expression and function of NK cell receptors in CD8 + T cells. Curr Opin Immunol 2001 13 : 465.
81. Gunturi A, Berg RE, Forman J. The role of CD94/NKG2 in innate and adaptive immunity. Immunol Res 2004 30 : 29.
82. McMahon CW, Zajac AJ, Jamieson AM et al. Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8(+) T cells. J Immunol 2002 169 : 1444.
83. Noppen C, Schaefer C, Zajac P et al. C-type lectin-like receptors in peptide-specific HLA class I-restricted cytotoxic T lymphocytes: differential expression and modulation of effector functions in clones sharing identical TCR structure and epitope specificity. Eur J Immunol 1998 28 : 1134.
84. Speiser DE, Pittet MJ, Valmori D et al. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J Exp Med 1999 190 : 775.
85. Tanaka J, Tutumi Y, Zhang L et al. Increased proportion of HLA-class-I-specific natural killer cell receptors (CD94) on peripheral blood mononuclear cells after allogeneic bone marrow transplantation. Acta Haematol 2001 105 : 89.
86. Tanaka J, Tutumi Y, Li Z et al. Induction of CD94/NKG2A expression on T cells in mixed lymphocyte culture by CD14+ cells from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Br J Haematol 2002 117 : 751.
87. LeMaoult J, Krawice-Radanne I, Dausset J, Carosella ED. HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci U S A 2004 101 : 7064.
88. Wiendl H, Mitsdoerffer M, Hofmeister V et al. The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy. Brain 2003 126 : 176.
89. Joly E, Hudrisier D. What is trogocytosis and what is its purpose?. Nat Immunol 2003 4 : 815.
90. Lemaoult J, Caumartin J, Daouya M et al. Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 2007 109 : 2040 2048.
91. Lila N, Carpentier A, Amrein C et al. Implication of HLA-G molecule in heart-graft acceptance. Lancet 2000 355 : 2138.
92. Lila N, Amrein C, Guillemain R et al. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 2002 105 : 1949.
93. Creput C, Durrbach A, Menier C et al. Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. J Hepatol 2003 39 : 587.
94. Malyguine AM, Saadi S, Platt JL, Dawson JR. Differential expression of natural killer cell markers: human versus baboon. Transplantation 1996 62 : 1319.
95. NIH Nonhuman Primate Reagent Resource Database of Cross-reactive Commercial Reagents. http://nhpreagents.bidmc.harvard.edu/NHP/ReagentList.aspx (January 5, 2007).
96. Knapp LA, Cadavid LF, Watkins DI. The MHC-E locus is the most well conserved of all known primate class I histocompatibility genes. J Immunol 1998 160 : 189.
97. Sidebottom DA, Kennedy R, Hildebrand WH. Class I MHC expression in the yellow baboon. J Immunol 2001 166 : 3983.
98. Langat DK, Hunt JS. Do nonhuman primates comprise appropriate experimental models for studying the function of human leukocyte antigen-G? Biol Reprod 2002 67 : 1367.
99. Slukvin II, Grendell RL, Rao DS et al. Cloning of rhesus monkey LILRs. Tissue Antigens 2006 67 : 331.